Targeting the IDO1 pathway in cancer: from bench to bedside

Overview of attention for article published in Journal of Hematology & Oncology, August 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#45 of 1,295)
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 4 news outlets
blogs: 1 blog

twitter: 2 X users
patent: 4 patents

Citations

dimensions_citation: 279 Dimensions

Readers on

mendeley: 284 Mendeley

Summary News Blogs X Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

Grant US-11207302-B2

United States of America

Modulators of indoleamine 2,3-dioxygenase and methods of using the same

Grant US-11192868-B2

United States of America

A DOSING REGIMEN FOR AN IDO INHIBITOR

Application WO-2021022172-A1

World Intellectual Property Organisation (WIPO)

ANTI-IDO ANTIBODY AND USES THEREOF

Application WO-2020117627-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.